1. Dzidzaria A.G., Pavlov A.Yu., Gafanov R.A. et al. Current issues in molecular diagnostics of bladder cancer. RMZh = RMJ 2019;(2):56-60. (In Russ.).
2. EAU Guidelines. Edn. Presented at the EAU Annual Congress Amsterdam, 2020.
3. Malignant tumors in Russia in 2018 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2019. 250 p. (In Russ.).
4. Mikhaylenko D.S., Sergienko S.A., Zaborsky I.N. et al. The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer. Onkourologiya = Cancer Urology 2018;14(4):124—38. (In Russ.). DOI: 10.17650/1726-9776-2018-144-124-138.
5. State of oncological care in Russia in 2018. Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMITS radiologii” Minzdrava Rossii, 2019. 236 p. (In Russ.).